Literature DB >> 20209975

[Effect of electroacupuncture of different acupoints on blood pressure, plasma angiotensin II, aldosterone and atrial natriuretic peptide in spontaneous hypertension rats].

Wan-ning Liu1, Lü-wei Jin, Dong-wei Han, Xiao-xuan Ren, Jiang Zhu, Lu-fen Zhang.   

Abstract

OBJECTIVE: To observe the effect of electroacupuncture (EA) of different acupoints on blood pressure (BP), plasma angiotensin (Ang) II, aldosterone (ALD) and atrial natriuretic peptide (ANP) of SHR, so as to observe the relative specificity of effects of acupoints.
METHODS: A total of 60 SHR were randomly divided into model, Quchi (LI 11), Zusanli (ST 36), Shenmen (HT 7), Jianyu (LI 15) and non-acupoint groups, with 10 cases in each. Other 10 Wistar rats were composed of normal group. EA (2 Hz, 2 mA) was applied to LI 11, ST 36, HT 7, LI 15 and non-acupoint for 30 min, followed by measuring BP with BP-6 system. Plasma Ang II, ALD and ANP contents were assayed by radioimmunoassay.
RESULTS: Compared with control group and pre-treatment, both systolic pressure (SP) and diastolic pressure (DP) of Quchi (LI 11), Zusanli (ST 36) and Shenmen (HT 7) groups lowered significantly (P<0.05). No significant differences were found in the SP and DP of Jianyu (LI 15) and non-acupoint groups (P>0.05). After EA, the SP of Quchi (LI 11) and Shenmen (HT 7) groups were significantly lower than that of Jianyu (LI 15) and non-acupoint groups (P<0.05); and the DP of Quchi (LI 11), Zusanli (ST 36) and Shenmen (HT 7) groups were markedly lower than that of Jianyu (LI 15) and non-acupoint groups (P<0.05). Compared with normal group, the contents of plasma Ang II and ANP of model group decreased significantly, and plasma ALD level of model group increased remarkably (P<0.05). Compared with model group, plasma AngII levels in Quchi (LI 11), Zusanli (ST 36) and Shenmen (HT 7) groups and ALD in Zusanli (ST 36) and Shenmen (HT 7) groups lowered significantly (P<0.05), and plasma ANP content in Shenmen (HT 7) group increased obviously (P<0.05).
CONCLUSION: EA of LI 11, HT 7 and ST 36 can effectively lowered both DP and SP in SHR, which may be closely related to its effects in regulating the contents of Ang II , ALD and ANP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20209975

Source DB:  PubMed          Journal:  Zhen Ci Yan Jiu        ISSN: 1000-0607


  5 in total

1.  Effect of electroacupuncture stimulation on expression of angiotensinogen, angiotensin II type 1 receptor, endothelin-1, and endothelin a receptor mRNA in spontaneously hypertensive rat aorta.

Authors:  Ze-Jun Huo; Dong Li; Jia Guo; Sai Li; Ning Ding; Zhi-Xin Li
Journal:  Chin J Integr Med       Date:  2016-07-13       Impact factor: 1.978

2.  The ameliorating effects of long-term electroacupuncture on cardiovascular remodeling in spontaneously hypertensive rats.

Authors:  Ze-Jun Huo; Quan Li; Gui-Hua Tian; Chang-Man Zhou; Xiao-Hong Wei; Chun-Shui Pan; Lei Yang; Yan Bai; You-Yi Zhang; Ke He; Chuan-She Wang; Zhi-Gang Li; Jing-Yan Han
Journal:  BMC Complement Altern Med       Date:  2014-04-01       Impact factor: 3.659

3.  Acupuncture Point Laterality: Investigation of Acute Effects of Quchi (LI11) in Patients with Hypertension Using Heart Rate Variability.

Authors:  Gerhard Litscher; Wei-Ping Cheng; Guang-Yu Cheng; Lu Wang; Jian Zhao; Daniela Litscher; Ingrid Gaischek; Zemin Sheng; Haixue Kuang
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-12       Impact factor: 2.629

4.  Attenuation of blood pressure in spontaneously hypertensive rats by acupuncture was associated with reduction oxidative stress and improvement from endothelial dysfunction.

Authors:  Sin Bond Leung; Hongwei Zhang; Chi Wai Lau; Zhi-Xiu Lin
Journal:  Chin Med       Date:  2016-08-30       Impact factor: 5.455

Review 5.  Acupuncture for Hypertension in Animal Models: A Systematic Review and Meta-Analysis.

Authors:  Ling-Yong Xiao; Zheng Li; Yu-Zheng Du; Hui-Yan Shi; Si-Qi Yang; Yue-Xin Zhang; Rui-Yu Li; Wan-Ling Lin; He-Yang Wang; Xiao-Yu Dai
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-11       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.